Long-term durability of percutaneous transluminal angioplasty in patients with symptomatic middle cerebral artery stenosis

Journal of Clinical Neurology (Korea)

Volumn 5, Issue 1, 2009, Pages 24-28

  Kim, Joon Tae ^a   Lee, Seung Han ^a   Choi, Seong Min ^b   Park, Man Seok ^a   Kim, Byeong Chae ^a   Yoon, Woong ^a   Kim, Jae Kyu ^a   Kim, Myeong Kyu ^a   Cho, Ki Hyun ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Research Institute of Medical Sciences   (South Korea)

Author keywords

Angioplasty; Middle cerebral artery; Restenosis; Saadurability

Indexed keywords

EID: 79251600656     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2009.5.1.24     Document Type: Article

References (17)

1. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of war farin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-1316.
2. Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The northern Manhattan stroke study. Stroke 1995;26:14-20.
3. SSYLVIA Study Investigators. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results. Stroke 2004;35:1388-1392.
4. Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine SR, Silli-man S, et al. The warfarin-aspirin symptomatic intracranial disease study. Neurology 1995;45:1488-1493.
5. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000;55: 490-497.
6. Mori T, Mori K, Fukuoka M, Arisawa M, Honda S. Percutaneous tran-sluminal cerebral angioplasty: serial angiographic follow-up after successful dilatation. Neuroradiology 1997;39:111-116.
7. Alazzaz A, Thornton J, Aletich VA, Debrun GM, Ausman JI, Charbel F. Intracranial percutaneous transluminal angioplasty for arteriosclero-tic stenosis. Arch Neurol 2000;57:1625-1630.
8. Mazighi M, Yadav JS, Abou-Chebl A. Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke 2008;39:1766-1769.
9. Yoon W, Seo JJ, Cho KH, Kim MK, Kim BC, Park MS, et al. Symptomatic middle cerebral artery stenosis treated with intracranial angi-oplasty: experience in 32 patients. Radiology 2005;237:620-626.
10. Kappelle LJ, Eliasziw M, Fox AJ, Sharpe BL, Barnett HJ. Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. The north American symptomatic carotid end arterectomy trail. Stroke 1999;30:282-286.
11. Demchuk AM, Christou I, Wein TH, Felberg RA, Malkoff M, Grotta JC, et al. Specific transcranial Doppler flow findings related to the presence and site of arterial occlusion. Stroke 2000;31:140-146.
12. Demchuk AM, Christou I, Wein TH, Felberg RA, Malkoff M, Grotta JC, et al. Accuracy and criteria for localizing arterial occlusion with transcranial Doppler. J Neuroimaging 2000;10:1-12.
13. Arenillas JF, Molina CA, Montaner J, Abilleira S, González-Sánchez MA, Alvarez-Sabín J. Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up trans-cranial Doppler ultrasound study. Stroke 2001;32:2898-2904.
14. Wojak JC, Dunlap DC, Hargrave KR, DeAlvare LA, Culbertson HS, Connors JJ. Intracranial angioplasty and stenting: long-term results from a single center. AJNR Am J Neuroradiol 2006;27:1882-1892.
15. Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Ma-saryk TJ. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial athero matous disease. Neurosurgery 2007;61: 236-242; discussion 242-233.
16. Lee JH, Kwon SU, Lee JH, Suh DC, Kim JS. Percutaneous trans-luminal angi-oplasty for symptomatic middle cerebral artery stenosis: long-term follow-up. Cerebrovasc Dis 2003;15:90-97.
17. Marks MP, Marcellus M, Norbash AM, Steinberg GK, Tong D, Al-bers G W. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999;30:1065-1069.